You are here

brain cancer

Orbus’s combo misses primary endpoint in Phase III brain cancer trial

Clinical Trials Arena

Mon, 11/25/24 - 09:25 am

Orbus Therapeutics

clinical trials

Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug

Pharma Voice

Mon, 11/18/24 - 11:12 am

Modifi Biosciences

Merck sets sights on brain cancer with $30M Modifi acquisition

Fierce Biotech

Wed, 10/23/24 - 11:41 am

Modifi Biosciences

Servier snags FDA approval for Voranigo, the 1st targeted therapy for a common type of brain tumor

Fierce Pharma

Tue, 08/6/24 - 05:57 pm

Ipsen builds again, licensing Day One glioma drug

Pharmaphorum

Thu, 07/25/24 - 11:10 am

Day One Biopharmaceuticals

Agios cashes in on cancer drug again with $905M Royalty Pharma deal

BioPharma Dive

Tue, 05/28/24 - 10:33 pm

US, EU regulators start swift reviews of Servier glioma drug

Pharmaphorum

Wed, 02/21/24 - 11:09 am

‘Kid-first’ startup BrainChild wants to shift the paradigm on pediatric cancer drugs

Fierce Biotech

Tue, 12/5/23 - 09:46 am

pediatric cancer

clinical trials

Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer

BioSpace

Tue, 08/22/23 - 09:44 am

Nascent Biotech

clinical trials

monoclonal antibodies

Doctors use precision medicine to show melanoma drugs can shrink rare brain tumor by 90%

Stat

Thu, 07/13/23 - 08:57 pm

precision medicine

papillary craniopharyngioma

Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy

BioPharma Dive

Wed, 05/17/23 - 11:21 am

Siren Biotechnology

cancer immunotherapy

Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer

Endpoints

Sun, 03/19/23 - 01:36 pm

NW Bio reports positive top-line results from phase 3 glioblastoma trial

Labiotech.eu

Mon, 11/21/22 - 07:23 pm

Northwest Biotherapeutics

clinical trials

VBI Vaccines gets orphan drug designation for glioblastoma therapy

Pharmaceutical Business Review

Wed, 06/22/22 - 10:55 am

Two days after showing strong pediatric cancer data, Day One taps $150M in public capital

Endpoints

Wed, 06/15/22 - 10:54 am

Day One Biopharmaceuticals

pediatric cancer

A new day for pediatric cancer patients: Day One's share price doubles on initial data for brain tumor drug

Fierce Biotech

Mon, 06/13/22 - 09:56 pm

Day One Biopharmaceuticals

pediatric cancer

pediatric low-grade glioma

Ultrasound Drug-Device Offers Diffuse Treatment for Glioblastoma Multiforme

Medical Devices and Diagnostics Industry

Mon, 12/20/21 - 11:29 pm

Alpheus Medical

drug-device combos

glioblastoma multiforme

Imvax raises $112M to advance brain cancer cell therapy

Fierce Biotech

Thu, 07/16/20 - 10:44 am

Bayer-backed Century buys Empirica to create brain cancer CAR-Ts

Fierce Biotech

Tue, 06/23/20 - 11:01 am

Century Therapeutics

Agios up as FDA gives Thermo Fisher glioma test breakthrough status

Pharmaforum

Tue, 06/16/20 - 10:35 am

Agios Pharmaceuticals

Pages